Skip to main content

Animations

MJFF Publications

4571 - 4580 of 6568 Results
Title
Year
  • Year
  • 2015
  • 2014
  • 2014
  • 2017
  • 2011
  • 2015
  • 2016
  • 2015
  • 2009
  • 2018
  • Summary Details
    OPEN
    Title: Disclosure of research results in genetic studies of Parkinson's disease caused by LRRK2 mutations
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26250
    Citation Count: 12
  • Summary Details
    OPEN
    Title: The effect of deep brain stimulation randomized by site on balance in Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.25831
    Citation Count: 53
  • Summary Details
    OPEN
    Title: The relationship between obsessive‐compulsive symptoms and PARKIN genotype: The CORE‐PD study
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26065
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-017-1792-9
    Citation Count: 226
  • Summary Details
    OPEN
    Title: Solution-Phase Parallel Synthesis and SAR of Homopiperazinyl Analogs as Positive Allosteric Modulators of mGlu4
    Journal Name: ACS Combinatorial Science
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/co1000508
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer’s disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-015-1395-2
    Citation Count: 56
  • Summary Details
    OPEN
    Title: Multiplex immunoassay characterization and species comparison of inflammation in acute and non-acute ischemic infarcts in human and mouse brain tissue
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-016-0371-y
    Citation Count: 75
  • Summary Details
    OPEN
    Title: Extracellular vesicle sorting of α-Synuclein is regulated by sumoylation
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-015-1408-1
    Citation Count: 166
  • Summary Details
    OPEN
    Title: Endpoints and Analyses to Discern Disease-Modifying Drug Effects in Early Parkinson’s Disease
    Journal Name: The AAPS Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1208/s12248-009-9123-2
    Citation Count: 68
  • Summary Details
    OPEN
    Title: Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsy
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-018-1900-5
    Citation Count: 63
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.